Truist Securities Reiterates argenx SE (ARGX) at Buy, ADAPT-SC Trial Sets Up for Success
Tweet Send to a Friend
Truist Securities analyst Joon Lee reiterated a Buy rating and $365.00 price target on argenx SE (NASDAQ: ARGX), following the ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
